全文获取类型
收费全文 | 102681篇 |
免费 | 7532篇 |
国内免费 | 376篇 |
专业分类
耳鼻咽喉 | 1129篇 |
儿科学 | 2535篇 |
妇产科学 | 1650篇 |
基础医学 | 14493篇 |
口腔科学 | 2193篇 |
临床医学 | 10488篇 |
内科学 | 21779篇 |
皮肤病学 | 1802篇 |
神经病学 | 10941篇 |
特种医学 | 4199篇 |
外国民族医学 | 6篇 |
外科学 | 14637篇 |
综合类 | 1252篇 |
一般理论 | 73篇 |
预防医学 | 7935篇 |
眼科学 | 1726篇 |
药学 | 6943篇 |
中国医学 | 111篇 |
肿瘤学 | 6697篇 |
出版年
2023年 | 573篇 |
2022年 | 1085篇 |
2021年 | 2148篇 |
2020年 | 1321篇 |
2019年 | 1979篇 |
2018年 | 2427篇 |
2017年 | 1790篇 |
2016年 | 2135篇 |
2015年 | 2479篇 |
2014年 | 3266篇 |
2013年 | 4299篇 |
2012年 | 6664篇 |
2011年 | 6711篇 |
2010年 | 3962篇 |
2009年 | 3611篇 |
2008年 | 5925篇 |
2007年 | 6433篇 |
2006年 | 5962篇 |
2005年 | 5903篇 |
2004年 | 5515篇 |
2003年 | 4916篇 |
2002年 | 4883篇 |
2001年 | 1874篇 |
2000年 | 1792篇 |
1999年 | 1667篇 |
1998年 | 1215篇 |
1997年 | 996篇 |
1996年 | 812篇 |
1995年 | 818篇 |
1994年 | 695篇 |
1993年 | 639篇 |
1992年 | 1156篇 |
1991年 | 1074篇 |
1990年 | 1017篇 |
1989年 | 979篇 |
1988年 | 869篇 |
1987年 | 815篇 |
1986年 | 837篇 |
1985年 | 830篇 |
1984年 | 671篇 |
1983年 | 580篇 |
1982年 | 556篇 |
1981年 | 456篇 |
1980年 | 397篇 |
1979年 | 522篇 |
1978年 | 408篇 |
1977年 | 368篇 |
1975年 | 327篇 |
1974年 | 355篇 |
1973年 | 344篇 |
排序方式: 共有10000条查询结果,搜索用时 13 毫秒
991.
GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles—continuous outcomes
Gordon H. Guyatt Kristian Thorlund Andrew D. Oxman Stephen D. Walter Donald Patrick Toshi A. Furukawa Bradley C. Johnston Paul Karanicolas Elie A. Akl Gunn Vist Regina Kunz Jan Brozek Lawrence L. Kupper Sandra L. Martin Joerg J. Meerpohl Pablo Alonso-Coello Robin Christensen Holger J. Schunemann 《Journal of clinical epidemiology》2013,66(2):173-183
Presenting continuous outcomes in Summary of Findings tables presents particular challenges to interpretation. When each study uses the same outcome measure, and the units of that measure are intuitively interpretable (e.g., duration of hospitalization, duration of symptoms), presenting differences in means is usually desirable. When the natural units of the outcome measure are not easily interpretable, choosing a threshold to create a binary outcome and presenting relative and absolute effects become a more attractive alternative.When studies use different measures of the same construct, calculating summary measures requires converting to the same units of measurement for each study. The longest standing and most widely used approach is to divide the difference in means in each study by its standard deviation and present pooled results in standard deviation units (standardized mean difference). Disadvantages of this approach include vulnerability to varying degrees of heterogeneity in the underlying populations and difficulties in interpretation. Alternatives include presenting results in the units of the most popular or interpretable measure, converting to dichotomous measures and presenting relative and absolute effects, presenting the ratio of the means of intervention and control groups, and presenting the results in minimally important difference units. We outline the merits and limitations of each alternative and provide guidance for meta-analysts and guideline developers. 相似文献
992.
993.
Annaheim B Rehm J Neuenschwander M Gmel G 《International journal of public health》2007,52(4):233-241
Summary Quitting hash. The readiness for behaviour change among cannabis users in Switzerland.
Objectives: The study aims to identify factors that are associated with the willingness of adolescents and young adults to modify their
cannabis use. It is hypothesized that frequency of use, cannabis-related problems and age of onset are associated with their
willingness to change.
Methods: In 2004, a survey on cannabis use was conducted among 13 to 29 year-olds living in Switzerland. Of the 5025 participants 593
had taken cannabis during the past six months. They were then asked about their willingness to change. Three groups of users
were compared: those not willing to change, those considering change, and those determined to change. Pearson Chi-square-tests
and logistic regressions were performed to test the hypotheses.
Results: Experience of problems motivates users to start thinking about changing their behavior. Frequent use and early onset are associated
with young people not making the transition from considering changing behavior to resolving to do so.
Conclusions: The need to perceive problematic use as a first step towards change and the inhibiting effect of dependencerelated factors
on the transition from consideration to determination calls for tailored intervention approaches that are matched to the willingness
to change.
Eingereicht: 10. Dezember 2005; überarbeitet: 13. September 2006; Angenommen: 6. M?rz 2007 相似文献
994.
Soongho Park Vinay Veluvolu William S. Martin Thien Nguyen Jinho Park Dan L. Sackett Claude Boccara Amir Gandjbakhche 《Biomedical optics express》2022,13(6):3187
We present a novel method that can assay cellular viability in real-time using supervised machine learning and intracellular dynamic activity data that is acquired in a label-free, non-invasive, and non-destructive manner. Cell viability can be an indicator for cytology, treatment, and diagnosis of diseases. We applied four supervised machine learning models on the observed data and compared the results with a trypan blue assay. The cell death assay performance by the four supervised models had a balanced accuracy of 93.92 ± 0.86%. Unlike staining techniques, where criteria for determining viability of cells is unclear, cell viability assessment using machine learning could be clearly quantified. 相似文献
995.
Josef Vodicka Jan Geiger Alexandra
idkov Pavel Andrle Hynek Mírka Martin Svaton Tom Kostlivý 《Annals of thoracic and cardiovascular surgery》2022,28(3):171
Purpose: The aims of this work were the retrospective analysis of a cohort of patients with acute mediastinitis treated at the authors’ worksite over a 15-year period and the identification of factors that significantly affect the outcomes of the therapy.Methods: During the period 2006–2020, 80 patients with acute mediastinitis were treated. Within the cohort, the following were observed: the causes and the type of acute mediastinitis, length of anamnesis, comorbidities, diagnostic methods, time from the diagnosis to surgery, types and number of surgical procedures, results of microbiological tests, complications, and outcomes of the treatment.Results: The most common type of acute mediastinitis was descending mediastinitis (48.75%). A total of 116 surgical procedures were performed. Ten patients in the cohort died (12.5%). Patients older than 60 years were at a 6.8 times higher risk of death. Patients with more than two comorbidities were at a 14.3 times higher risk of death. The presence of yeasts in the culture material increased the risk of death by 4.4 times.Conclusion: Early diagnosis, removal of the cause of mediastinitis, sufficient mediastinal debridement, and multiple drainage thereof with the possibility of continual postoperative lavage are essential for the successful treatment of acute mediastinitis. 相似文献
996.
Ricard Navins Giovanni Oriolo Igor Horrillo Myriam Cavero Bruno Aouizerate Martin Schaefer Lucile Capuron J Javier Meana Rocio Martin-Santos 《The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)》2022,25(6):468
BackgroundThe relationship between antidepressant response and glial, inflammatory, and metabolic markers is poorly understood in depression. This study assessed the ability of biological markers to predict antidepressant response in major depressive disorder (MDD).MethodsWe included 31 MDD outpatients treated with escitalopram or sertraline for 8 consecutive weeks. The Montgomery-Åsberg Depression Rating Scale (MADRS) was administered at baseline and at week 4 and 8 of treatment. Concomitantly, blood samples were collected for the determination of serum S100B, C-reactive protein (CRP), and high-density lipoprotein cholesterol (HDL)-C levels. Treatment response was defined as ≥50% improvement in the MADRS score from baseline to either week 4 or 8. Variables associated with treatment response were included in a linear regression model as predictors of treatment response.ResultsTwenty-seven patients (87%) completed 8 weeks of treatment; 74% and 63% were responders at week 4 and 8, respectively. High S100B and low HDL-C levels at baseline were associated with better treatment response at both time points. Low CRP levels were correlated with better response at week 4. Multivariate analysis showed that high baseline S100B levels and low baseline HDL-C levels were good predictors of treatment response at week 4 (R2 = 0.457, P = .001), while S100B was at week 8 (R2 = 0.239, P = .011). Importantly, baseline S100B and HDL-C levels were not associated with depression severity and did not change over time with clinical improvement.ConclusionsSerum S100B levels appear to be a useful biomarker of antidepressant response in MDD even when considering inflammatory and metabolic markers. 相似文献
997.
998.
Hannah Reemtsma Cora M. Holicki Christine Fast Felicitas Bergmann Martin Eiden Martin H. Groschup Ute Ziegler 《Viruses》2022,14(6)
West Nile virus (WNV) is an emerging infectious pathogen circulating between mosquitoes and birds but also infecting mammals. WNV has become autochthonous in Germany, causing striking mortality rates in avifauna and occasional diseases in humans and horses. We therefore wanted to assess the possible role of free-ranging poultry in the WNV transmission cycle and infected 15 goslings with WNV lineage 2 (German isolate). The geese were monitored daily and sampled regularly to determine viremia, viral shedding, and antibody development by molecular and serological methods. Geese were euthanized at various time points post-infection (pi). All infected geese developed variable degrees of viremia from day 1 to day 10 (maximum) and actively shed virus from days 2 to 7 post-infection. Depending on the time of death, the WN viral genome was detected in all examined tissue samples in at least one individual by RT-qPCR and viable virus was even re-isolated, except for in the liver. Pathomorphological lesions as well as immunohistochemically detectable viral antigens were found mainly in the brain. Furthermore, all of the geese seroconverted 6 days pi at the latest. In conclusion, geese are presumably not functioning as important amplifying hosts but are suitable sentinel animals for WNV surveillance. 相似文献
999.
Akshitha Thatiparthi Amylee Martin Jeffrey Liu Jashin J. Wu 《The Journal of clinical and aesthetic dermatology》2022,15(6):68
Phototherapy is a standard treatment for moderate-to-severe psoriasis. However, concern remains regarding the associated cutaneous carcinogenic risk. Our objective is to conduct a systematic review of skin cancer risk for psoriasis patients treated with phototherapy. To achieve our goal, we searched Cochrane, PubMed, and Embase databases. We aimed to evaluate existing literature (from July 1, 2010, to December 31, 2020) on phototherapy for all Fitzpatrick skin phototypes (FSP) which includes 71 articles, and eight articles being categorized in this review. Five studies did not report an increased skin cancer risk with narrowband-ultraviolet blue (UVB) and unspecified UVB for FSP II through VI, with one study not reporting FSP. Three studies did report an increased risk of skin cancer with narrowband-UVB and broadband-UVB for FSP I-VI, with one study also not specifying skin phototypes or UVB phototherapy type. Additionally, a study with psoralen and ultraviolet A with and without narrowband-UVB demonstrated an increased risk of skin cancer in phototypes III and IV. The most commonly reported secondary outcomes with phototherapy were actinic keratosis (123) and solar lentigines (10). Numerous patients were also on additional therapies including methotrexate, acitretin, and biologics. Study limitations include publication bias due to limited number of studies published on this topic in the last ten years along with heterogeneity in reporting. The relationship between phototherapy, psoriasis, and cutaneous oncogenic risk remains contradictory. While phototherapy for psoriasis is an efficacious therapy, further studies are needed to understand the cutaneous oncogenic risk based on FSP to help clinicals tailor treatment recommendations based on skin phototypes. 相似文献
1000.
Jessica Hong Hyung Joon Kwon Raul Cachau Catherine Z. Chen Kevin John Butay Zhijian Duan Dan Li Hua Ren Tianyuzhou Liang Jianghai Zhu Venkata P. Dandey Negin P. Martin Dominic Esposito Uriel Ortega-Rodriguez Miao Xu Mario J. Borgnia Hang Xie Mitchell Ho 《Proceedings of the National Academy of Sciences of the United States of America》2022,119(18)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike is a trimer of S1/S2 heterodimers with three receptor-binding domains (RBDs) at the S1 subunit for human angiotensin-converting enzyme 2 (hACE2). Due to their small size, nanobodies can recognize protein cavities that are not accessible to conventional antibodies. To isolate high-affinity nanobodies, large libraries with great diversity are highly desirable. Dromedary camels (Camelus dromedarius) are natural reservoirs of coronaviruses like Middle East respiratory syndrome CoV (MERS-CoV) that are transmitted to humans. Here, we built large dromedary camel VHH phage libraries to isolate nanobodies that broadly neutralize SARS-CoV-2 variants. We isolated two VHH nanobodies, NCI-CoV-7A3 (7A3) and NCI-CoV-8A2 (8A2), which have a high affinity for the RBD via targeting nonoverlapping epitopes and show broad neutralization activity against SARS-CoV-2 and its emerging variants of concern. Cryoelectron microscopy (cryo-EM) complex structures revealed that 8A2 binds the RBD in its up mode with a long CDR3 loop directly involved in the ACE2 binding residues and that 7A3 targets a deeply buried region that uniquely extends from the S1 subunit to the apex of the S2 subunit regardless of the conformational state of the RBD. At a dose of ≥5 mg/kg, 7A3 efficiently protected transgenic mice expressing hACE2 from the lethal challenge of variants B.1.351 or B.1.617.2, suggesting its therapeutic use against COVID-19 variants. The dromedary camel VHH phage libraries could be helpful as a unique platform ready for quickly isolating potent nanobodies against future emerging viruses.Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of COVID-19 (1, 2) that enters human cells by binding its envelope anchored type I fusion protein (spike) to angiotensin-converting enzyme 2 (ACE2) (3, 4). The SARS-CoV-2 spike is a trimer of S1/S2 heterodimers with three ACE2 receptor-binding domains (RBDs) attached to the distal end of the spike via a hinge region that allows conformational flexibility (4). In the all-down conformation, the RBDs are packed with their long axes contained in a plane perpendicular to the axis of symmetry of the trimer. Transition to the roughly perpendicular up conformation exposes the receptor-binding motif (RBM), located at the distal end of the RBD, which is sterically occluded in the down state. Numerous neutralizing antibodies targeting the spike, particularly its RBD, have been developed to treat COVID-19 using common strategies such as single B cell cloning, animal immunization, and phage display (5–9). Most vaccines, including those that are messenger RNA based, are designed to induce immunity against the spike or RBD (10–12). However, emerging SARS-CoV-2 variants such as D614G, B.1.1.7 (Alpha, United Kingdom), B.1.351 (Beta, South Africa), and P.1 (Gamma, Brazil) have exhibited increased resistance to neutralization by monoclonal antibodies or postvaccination sera elicited by the COVID-19 vaccines (13, 14). Monoclonal antibodies with Emergency Use Authorization for COVID-19 treatment partially (Casirivimab) or completely (Bamlanivimab) failed to inhibit the B.1.351 and P.1 variants. Similarly, these variants were less effectively inhibited by convalescent plasma and sera from individuals vaccinated with a COVID-19 vaccine (BNT162b2) (13). The B.1.617.2 (Delta, India) variant became the prevailing strain in many countries (15). Highly effective and broadly neutralizing antibody therapy is urgently demanded for COVID-19 patients.Due to their small size and unique conformations, camelid VHH single-domain antibodies (also known as nanobodies) can recognize protein cavities that are not accessible to conventional antibodies (16). To isolate high-affinity nanobodies without a need for further affinity maturation, it is highly desirable to construct large nanobody libraries with great diversity. Dromedary camels have been found as potential natural reservoirs of Middle East respiratory syndrome CoV (MERS-CoV) (17). We speculated that dromedary camels would be an ideal source of neutralizing nanobodies against coronaviruses. In the present study, we built large camel VHH single-domain antibody phage libraries with a diversity of over 1011 from six dromedary camels (Camelus dromedarius), three males and three females, with ages ranging from 3 mo to 20 y. We used both the SARS-CoV-2 RBD and the stabilized spike ectodomain trimer protein as baits to conduct phage panning for nanobody screening. Among all the binders, we found NCI-CoV-7A3 (7A3), NCI-CoV-1B5 (1B5), NCI-CoV-8A2 (8A2), and NCI-CoV-2F7 (2F7) to be potent ACE2 blockers. In addition, these dromedary camel nanobodies displayed potent neutralization activity against the B.1.351 and B.1.1.7 variants and the original strain (Wuhan-Hu-1). The cryoelectron microscopy (cryo-EM) structure of the spike trimer protein complex with these VHH nanobodies revealed two distinct nonoverlapping epitopes for neutralizing SARS-CoV-2. In particular, 7A3 recognizes a unique and deeply buried region that extends to the apex of the S2 subunit of the spike. Combined treatment with 7A3 and 8A2 shows more potent protection against various variants in culture and mice infected with the B.1.351 variant. Interestingly, 7A3 alone retains its neutralization activity against the lethal challenge of the B.1.617.2 variant in mice. 相似文献